Relationship between uncoupling protein 1 (UCP1) levels and psoriasis

Area of Science:

• Biochemistry
• Dermatology
• Immunology

Background:

• Psoriasis is a chronic autoimmune skin condition with increased mortality risk due to comorbidities.
• Uncoupling protein 1 (UCP1) role in psoriasis pathogenesis is not well understood.
• Investigating UCP1 in psoriasis may reveal insights into disease mechanisms and cardiovascular risk.

Purpose of the Study:

• To examine uncoupling protein 1 (UCP1) levels in psoriasis patients.
• To assess the correlation between UCP1 levels and psoriasis severity, dyslipidemia, inflammation, and cardiovascular risk.
• To evaluate UCP1 as a potential biomarker for psoriasis diagnosis.

Main Methods:

• Serum UCP1 levels were measured in 30 psoriasis patients and 30 healthy controls using ELISA.
• Psoriasis Area and Severity Index (PASI) scores were used to assess disease severity.
• Biochemical parameters including high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein were analyzed.

Main Results:

• UCP1 demonstrated significant predictive value for psoriasis (AUC: 0.708, p = 0.002).
• Lower UCP1 levels (< 7.561) were associated with a reduced probability of developing psoriasis (OR: 0.27, p = 0.039).
• Psoriasis patients exhibited elevated high-sensitivity C-reactive protein and triglyceride levels, and lower high-density lipoprotein levels compared to controls.

Conclusions:

• UCP1 may serve as a valuable diagnostic marker for psoriasis in both symptomatic and asymptomatic stages, with notable sensitivity and specificity.
• Further research is required to confirm the diagnostic and prognostic utility of UCP1 in psoriasis.
• Altered lipid profiles and inflammation markers in psoriasis patients highlight the systemic nature of the disease.